Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Anbergen

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Nanomedicine (London, England)|September 19, 2023
Nanomedicine approaches for <i>in vivo</i> cancer immunotherapyStijn Rj Hofstraat, Tom Anbergen, Roy van der Meel
Nature Reviews Bioengineering|April 17, 2023
Engineering cytokine therapeuticsJeroen Deckers, Tom Anbergen, Ayla M Hokke, et al.
Bioconjugate Chemistry|July 11, 2025
Engineering Fusion Proteins for Nanomedicine-Based Cytokine TherapyAnne de Dreu, Koen de Bruin, Ayla M Hokke, et al.
Advanced Materials (Deerfield Beach, Fla.)|September 12, 2025
Dendrimers Improve Apolipoprotein Nanoparticle mRNA Delivery to Immune CellsMirre M Trines, Daniek Hoorn, Stijn R J Hofstraat, et al.
Nature Biomedical Engineering|June 8, 2023
Resolving sepsis-induced immunoparalysis via trained immunity by targeting interleukin-4 to myeloid cellsDavid P Schrijver, Rutger J Röring, Jeroen Deckers, et al.
Research Square|April 3, 2026
Delivering cytokine mRNA to secondary lymphoid organs for robust cancer immunotherapyWillem Mulder, Tom Anbergen, Yuri van Elsas, et al.
Nature Nanotechnology|February 3, 2025
Nature-inspired platform nanotechnology for RNA delivery to myeloid cells and their bone marrow progenitorsStijn R J Hofstraat, Tom Anbergen, Robby Zwolsman, et al.
Nature Nanotechnology|July 31, 2024
Polymersomes with splenic avidity target red pulp myeloid cells for cancer immunotherapyAnnelies C Wauters, Jari F Scheerstra, Mandy M T van Leent, et al.
Science Advances|January 1, 2026
Systemically inducing trained immunity overcomes solid tumors' immunosuppressive microenvironmentBram Priem, Lisa Willemsen, Tom Anbergen, et al.
Iscience|April 3, 2025
Targeting mTOR in myeloid cells prevents infection-associated inflammationYohana C Toner, Jazz Munitz, Geoffrey Prevot, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Nanomedicine (London, England)|September 19, 2023
Nanomedicine approaches for <i>in vivo</i> cancer immunotherapyStijn Rj Hofstraat, Tom Anbergen, Roy van der Meel
Nature Reviews Bioengineering|April 17, 2023
Engineering cytokine therapeuticsJeroen Deckers, Tom Anbergen, Ayla M Hokke, et al.
Bioconjugate Chemistry|July 11, 2025
Engineering Fusion Proteins for Nanomedicine-Based Cytokine TherapyAnne de Dreu, Koen de Bruin, Ayla M Hokke, et al.
Advanced Materials (Deerfield Beach, Fla.)|September 12, 2025
Dendrimers Improve Apolipoprotein Nanoparticle mRNA Delivery to Immune CellsMirre M Trines, Daniek Hoorn, Stijn R J Hofstraat, et al.
Nature Biomedical Engineering|June 8, 2023
Resolving sepsis-induced immunoparalysis via trained immunity by targeting interleukin-4 to myeloid cellsDavid P Schrijver, Rutger J Röring, Jeroen Deckers, et al.
Research Square|April 3, 2026
Delivering cytokine mRNA to secondary lymphoid organs for robust cancer immunotherapyWillem Mulder, Tom Anbergen, Yuri van Elsas, et al.
Nature Nanotechnology|February 3, 2025
Nature-inspired platform nanotechnology for RNA delivery to myeloid cells and their bone marrow progenitorsStijn R J Hofstraat, Tom Anbergen, Robby Zwolsman, et al.
Nature Nanotechnology|July 31, 2024
Polymersomes with splenic avidity target red pulp myeloid cells for cancer immunotherapyAnnelies C Wauters, Jari F Scheerstra, Mandy M T van Leent, et al.
Science Advances|January 1, 2026
Systemically inducing trained immunity overcomes solid tumors' immunosuppressive microenvironmentBram Priem, Lisa Willemsen, Tom Anbergen, et al.
Iscience|April 3, 2025
Targeting mTOR in myeloid cells prevents infection-associated inflammationYohana C Toner, Jazz Munitz, Geoffrey Prevot, et al.
Pageof 1